Literature DB >> 19197257

Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women.

Inmaculada Simón1, Xavier Escoté, Núria Vilarrasa, José Gómez, José M Fernández-Real, Ana Megía, Cristina Gutiérrez, Lluis Gallart, Carles Masdevall, Joan Vendrell.   

Abstract

The aim of the study was to evaluate human plasma circulating levels of adipocyte fatty acid-binding protein (A-FABP) and its relationship with proinflammatory adipocytokines and insulin resistance in a severely obese cohort, before and 1 year after a surgical gastric bypass. Plasmatic levels of A-FABP were measured in 77 morbid-obese women before and 1 year after bariatric surgery. Anthropometrical parameters and body composition by bioelectrical impedance analysis were determined. Circulating levels of soluble tumor necrosis factor receptor 2 (sTNFR2), Interleukin 18 (IL-18), adiponectin, and high-sensitive C-reactive protein (hsCRP) were also analyzed. Insulin resistance by homeostasis model assessment of insulin resistance (HOMA-IR) index was calculated. After massive weight loss, A-FABP plasmatic levels decreased significantly [7.6 (8.9) vs. 4.3 (5.1); P<0,001] but no association with circulating adipokines or proinflammatory cytokines, both at the beginning and at the end of follow-up, was observed. A decrease in sTNFR2, IL-18, hsCRP, and an increase in adiponectin levels (P<0.001 in all cases) were observed after the gastric bypass. HOMA-IR index improved 1 year after surgery and after multiple regression analysis remained associated with A-FABP after controlling for confounding variables (beta=0.322, P=0.014; R2 for the model 0.281). In morbid-obese women, plasma A-FABP concentrations were dramatically reduced after gastric bypass surgery. After weight loss this protein contributed to HOMA-IR index independently of proinflammatory/antinflammatory cytokine profile. Further studies are warranted to elucidate the role of A-FABP in the pathogenesis of insulin resistance in morbid obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19197257     DOI: 10.1038/oby.2008.665

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  19 in total

Review 1.  Adipocytokines in obesity and metabolic disease.

Authors:  Haiming Cao
Journal:  J Endocrinol       Date:  2014-01-08       Impact factor: 4.286

Review 2.  Therapeutic applications of conditioned medium from adipose tissue.

Authors:  Minjia Dai; Yan Zhang; Mei Yu; Weidong Tian
Journal:  Cell Prolif       Date:  2016-08-04       Impact factor: 6.831

Review 3.  Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease?

Authors:  S Kralisch; M Fasshauer
Journal:  Diabetologia       Date:  2012-09-29       Impact factor: 10.122

4.  Plasma levels of FABP4, but not FABP3, are associated with increased risk of diabetes.

Authors:  Luc Djoussé; J Michael Gaziano
Journal:  Lipids       Date:  2012-06-16       Impact factor: 1.880

5.  Increased serum nitric oxide concentration after bariatric surgery--a potential mechanism for cardiovascular benefit.

Authors:  Tomasz Sledzinski; Maciej Sledzinski; Ryszard Tomasz Smolenski; Julian Swierczynski
Journal:  Obes Surg       Date:  2009-12-08       Impact factor: 4.129

6.  Cord Blood Adipocyte Fatty Acid-Binding Protein Levels Correlate With Gestational Age and Birth Weight in Neonates.

Authors:  Kyoung Eun Joung; Sule Umit Cataltepe; Zoe Michael; Helen Christou; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 7.  Obesity-related insulin resistance: implications for the surgical patient.

Authors:  N Tewari; S Awad; I A Macdonald; D N Lobo
Journal:  Int J Obes (Lond)       Date:  2015-06-01       Impact factor: 5.095

Review 8.  Effect of Bariatric Surgery on Serum Inflammatory Factors of Obese Patients: a Systematic Review and Meta-Analysis.

Authors:  Moein Askarpour; Dana Khani; Ali Sheikhi; Ehsan Ghaedi; Shahab Alizadeh
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

9.  Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study.

Authors:  Luc Djoussé; Traci M Bartz; Joachim H Ix; Jinesh Kochar; Jorge R Kizer; John S Gottdiener; Russell P Tracy; Dariush Mozaffarian; David S Siscovick; Kenneth J Mukamal; Susan J Zieman
Journal:  Eur J Heart Fail       Date:  2012-12-06       Impact factor: 15.534

Review 10.  Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.

Authors:  John N Fain
Journal:  Mediators Inflamm       Date:  2010-05-23       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.